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ABSTRACT  The role of phenomena analogous to fibroblast contact  inhibition  in  lymphocyte 
growth  regulation  is controversial,  although  it  is clear that direct  cell-cell  contact  is vital  to 
immunoregulation  and accessory cell function.  An extract of mouse liver  plasma membrane 
proteins,  referred  to  as  suppressive  liver  extract  (SLE), that  suppresses the  growth  of  3T3 
fibroblasts also inhibited the mitogen-induced  proliferation of murine lymphocytes. A dose of 
20 /~g/ml SLE  was >95%  suppressive  of  proliferation  in  both  mouse  T  and  mouse  B cells 
treated with a variety of mitogens. B cell growth factor, while increasing DNA synthesis overall 
in  mitogen-stimulated  B cells, did  not change the extent of SLE suppression, which suggests 
that the  SLE does  not  interfere  with  lymphocyte-growth  factor  interactions.  In  exploring  a 
sequence  of  B cell  activation  events,  we  discovered  that  SLE  had  no  effect  on  the  early 
activation  event  of  increased  phosphatidylinositol  turnover.  Blastogenesis,  however,  was 
inhibited  in  mitogen-stimulated,  SLE-treated  B cells.  The  maximum  suppressive  effect  was 
observed if the SLE was added within 8-12 h of the mitogenic stimulus. SLE did not affect the 
viability  of cells in culture.  These results point to a possible unity of regulatory  mechanisms 
between contact inhibition  in fibroblasts and the processes of immunoregulation. 
Regulation and control of celt proliferation is poorly under- 
stood. One approach to understanding the regulation of cell 
growth has been the study of the density-dependent inhibition 
of fibroblast proliferation. Fibroblasts,  when grown to con- 
fluency in  culture,  cease  dividing  while  retaining  viability. 
The challenge has been to ascertain the nature of the factor 
or factors responsible for this growth regulation (1).  In this 
regard,  it  has  been  demonstrated  that  peptide  factors that 
regulate  cell  growth  are  located  on  the  cell  surface.  Both 
growth inhibitory and growth stimulatory factors have been 
identified  in  preparations of plasma membranes from cul- 
tured mouse and human fibroblasts (1-4), cultured rat hepa- 
tocytes (5), and mouse liver (6). Cells released from "normal" 
growth regulation (transformed cells) express these factors on 
their cell surfaces but do not respond to them (1, 6,  7). The 
growth inhibitory membrane factors appear to act by revers- 
ibly  halting  the  progression  of fibroblasts through  the  G1 
phase of the cell cycle at the same point as serum deprivation 
(8,  9).  These inhibitory factors also induce  other responses 
normally associated with high cell density growth arrest, such 
as an increase in the number of  receptors for epidermal growth 
factor (10) and the induction of tyrosine aminotransferase in 
hepatocytes (11).  The contention  that  these  factors are ac- 
tually  peptides  is  supported  by the  observation  that  their 
suppressive action on fibroblasts is heat and acid labile (1, 8), 
and the further indication that the activity of the solubilized 
product is not affected by total delipidation (12). 
One system in which cell-cell interactions are thought to 
play a  significant role in  growth  regulation  is the  immune 
system. This system requires that immunocompetent lympo- 
cytes be in a resting state (GO) until triggered by appropriate 
stimuli.  The lymphocytes then  enter the  cell  cycle, during 
which they enlarge in size, proliferate, and reach terminally 
differentiated functional status. Each stage of this progression 
is critically regulated by interactions between lymphocytes, as 
well as between these cells and accessory cells such as mono- 
cytes and dendritic cells.  The purpose of this  study was to 
detemine if  the presence of exogenous growth inhibitory factor 
obtained from mouse liver membranes inhibited the  mito- 
genic response of murine T and B lymphocytes. Mouse liver 
membrane extracts inhibit fibroblast growth (6); this indicates 
inhibitory  cross-reactivity between  these  two  different  cell 
types. The demonstration of inhibition of lymphocyte prolif- 
eration would be consistent with the notion that this system 
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a wide range of  cell types. Our results indicate that suppressive 
liver extract (SLE) ~ from mouse liver blocked the mitogen- 
induced proliferation of mouse T and B cells. This effect was 
labile to heat treatment and resistant to delipidation of the 
SLE.  The maximum inhibitory effect of the  SLE occurred 
within  12 h  of mitogenic stimulus. Because of this, we also 
examined the effect of SLE on an early event, namely phos- 
phatidylinositoi turnover. The early activation of phosphati- 
dylinositol metabolism, which is an early event in cell acti- 
vation in both T ( 13,  14) and B (15) cells, was not significantly 
influenced by SLE. These results indicate possible similarity 
of mechanisms between contact inhibition  and lymphocyte 
growth regulation. 
MATERIALS AND  METHODS 
Mice:  Male  BALB/c mice were obtained  from Harlan Sprague Dawley, 
Inc., Indianapolis,  IN, and were used between 6 and 12 wk of age. 
Lymphocyte Isolation and Purification:  B  cells were isolated 
from mouse spleen and purified as described previously (15). Briefly, spleens 
were harvested from mice treated with anti-thymocyte  serum (M. A. Bioprod- 
ucts,  Walkersville, MD),  the  cells isolated,  and the erythrocytes  lysed. The 
splenocytes  were then depleted  of adherent  cells (primarily  monocytes)  by 
incubation  for l h at 37"C in glass petri dishes (20 ml/plate)  at 2 x  l06 cells/ 
ml in RPMI  1640 plus penicillin/streptomycin,  glutamine (complete medium), 
and  10%  fetal bovine  serum (FBS). The remaining  T cells were depleted  by 
treatment with cytotoxic  monoclonal  antibodies  to T  cell markers,  anti-thy- 
mocyte  serum,  and  complement.  Cells thus treated  were >90%  positive for 
surface ig and had  <5%  T  cells as determined  by  flow cytometric  analysis. 
Mouse T cells were isolated from spleens of untreated  mice after erythrocyte 
lysis and glass plate adherence.  Viabilities of cells used as determined  by the 
method of fluorescein/ethidium  bromide staining (16) were always in excess of 
90%. 
Assay of DNA Synthesis:  Mouse T cells were suspended in complete 
medium plus 10%  FBS at  10  ~ cells/0.24  ml/well  in 96-well microtiter  plates 
(Corning Glass Works, Coming, NY). Mouse enriched B cells were suspended 
in the same medium with 300 vM beta-mercaptoethanol  at 2 x  105 cells/0.24 
ml/well.  Mitogens were added to cultures at time zero, (3H-methyl)thymidine 
(SH-TdR) ( 1  vCi/well, 6.7 Ci/mmole) (ICN K & K Laboratories Inc., Plainview, 
NY) was added at 62 h, and the cultures were harvested at 72 h on glass fiber 
filter strips. All incubations  were at 37"C in a 5% CO2 atmosphere. Total  3H- 
TdR incorporation  was determined  by liquid scintillation spectrometry  using 
2 ml of scintillation cocktail 4a20 (Research Products International  Corp., Mr. 
Prospect, IL). Each data point was obtained in triplicate. Percentage suppression 
was calculated as incorporation  at a given suppressive dose divided by control 
incorporation  (mitogen in the absence of SLE). 
Assay of Phospholipid Metabolism:  Phosphatidylinositolmetab- 
olism  in B cells was assayed as described elsewhere (15). Briefly, enriched  B 
cells were suspended in phosphate-free complete medium plus 2% phosphate- 
free FBS (FBS was dialzyed extensively against phosphate-free medium) at 2 x 
106 cells/ml  in  1-ml tube cultures, treated with 50 ug/ml anti-lgM, and then 
incubated at 37"C. 100 #Ci 32pi (1CN K & K Laboratories Inc.) was added 2 h 
before  harvest,  at  which  time  the cells were washed  and the  phospholipids 
extracted  by  a  modified  Folch  extraction  (17). The  extracted  lipids  were 
chromatographed  on oxalate-treated  high performance  thin layer chromatog- 
raphy plates (MCB Reagents, Gibbstown,  NJ)  in a tank equilibrated  with a 
solvent  system  of chloroform,  acetone,  methanol,  acetic acid, and  water 
(40:15:13:12:8, vol/vol) for 3.5 h (18). Phospholipid standards (Sigma Chemical 
Co., St. Louis, MO) were added to cell lipid extracts and visualized in an iodine 
tank  to confirm the equilibrium  position of each phospholipid  species. Auto- 
radiograms were obtained  and the spots corresponding  to each  phospholipid 
species  were  scraped  off and  counted  in  a  liquid  scintillation  counter  as 
described above. 
Cell Size  Characterization:  Cells  were cultured  at 37"C in 24-well 
cluster  plates (Corning  Glass Works) at  106 cells/ml/well  complete  medium 
plus  10% FBS. The cells were resuspended at various times after mitogen and 
SLE addition, and 0.2 ml of the resuspended cells was added to 9.8 ml of Isoton 
J  Abbreviations used in this paper."  BCGF, B cell growth factor; FBS, 
fetal  bovine serum; 3H-TdR,  (3H-methyl)thymidine; LPS,  lipopoly- 
saccharide; SLE, suppressive liver extract. 
for cell size analysis on a Coulter  Model ZM  Counter/Channelizer  (Coulter 
Electronics Inc., Hialeah, FL). The data were analyzed and stored on an Apple 
IIe microcomputer. 
Mitogens:  For the T cells, phytohemagglutinin  (Sigma Chemical Co.) 
and concanavalin  A (Sigma Chemical Co.) were used at  l0 ~g/ml and 3 t@/ 
ml, respectively. For the B cells, E. coli lipopolysaccharide (LPS) 055:b5 (W) 
(Difco Laboratories Inc., Detroit,  MI) and the F(ab')2 fragment of goat anti- 
mouse IgM (mu chain  specific) (CooperBiomedical, Inc., Malvern, PA) were 
each used at 50 ~g/ml. B cell growth factor (BCGF) activity was obtained from 
conditioned media of EL-4 cells, a murine thymoma that produces BCGF ( 19, 
20). EL-4 cells were cultured at l06 cells/ml in complete medium plus 1% FBS 
with l0 ng/ml phorbol myristate acetate. After 48 h at 37"C, the medium was 
centrifuged and the supernatant  collected and passed over activated charcoal. 
This conditioned  medium contained  BCGF activity with no IL-2 activity, as 
assayed with mouse enriched B cells and the IL-2 dependent line CTLL-2 (21 ). 
Preparation of SLE from Mouse Liver:  Mouse liver membranes 
were prepared following the protocol devised by Aronson and Toaster for the 
preparation  of rat  liver membranes (22). This procedure  consists of cell ho- 
mogenization by a motor-driven teflon pestle, differential low speed centrifuga- 
tions to remove  nuclei and whole cells, and flotation  of various membrane 
fractions in a discontinuous high speed sucrose gradient. The original procedure 
described the isolation of membrane-rich  fractions from both cell and nuclei: 
for the studies described in this paper only cellular membranes were collected. 
Typical membrane preparations showed a 10-15-fold enrichment  for a plasma 
membrane marker (alkaline phosphodiesterase) with very little enrichment  for 
any other organelle. Membrane  could  be  stored  at  -70"C  for  up to 6  mo 
without any appreciable loss of  growth inhibitory activity. Membranes prepared 
in this fashion have been shown to contain both growth stimulatory and growth 
inhibitory activities when added to mouse fibroblasts in culture (6). 
Soluble growth  inhibitory  fractions were prepared  by first extracting  the 
membranes three times with 0.13 M sodium pyrophosphate/0.1  mM dithio- 
threitol,  pH  7.4, for 60  minutes  at 4"C. Such  extractions  remove  a growth 
stimulatory activity from the membrane (6) while leaving the inhibitory com- 
ponent in the membrane.  The pyrophosphate-treated  membranes were then 
extracted with dimethyl maleic anhydride as described by Raben et al. (12) for 
solubilization of a 3T3 cell growth inhibitory factor. Briefly, membranes at 160 
ug/ml in 0.7 mM Tris-HC1, 0.07 mM EDTA, had dimethyl maleic anhydride 
added to 2 mg/ml final concentration  after adjusting the pH to 8.5 with 1 N 
NaOH. The pH was kept at 8-8.5 by the addition of I N NaOH as the reaction 
proceeded. When acid evolution stopped (after ~45 min), the membranes were 
recovered by centrifugation and solubilized by the addition of 30 mM octylglu- 
coside in  10 mM potassium  phosphate, 0.1  mM dithiothreitol,  pH 7.4 (octyl- 
glucoside buffer), and incubated  for 45 min at 4"C at a protein concentration 
of  0.63 mg/ml. Centrifugation at 50,000 g for 45 min then clarified the extract, 
and the supernatant  was treated with 0.1  vol of 1 M sodium acetate, pH 4.0. 
This procedure  precipitates the growth inhibitory  activity as well as removes 
any dimethylmaleyl groups which may be on the membrane.  Centrifugation 
(50,000 g for 45 min) recovered the pellet which was solubilized a second time 
with octylgiucoside as described  above. The resultant  supernatant  was then 
dialyzed extensively against  5 mM  HEPES, 0.1  mM  dithiothreitol,  pH  7.4 
(buffer A),  and  stored  at  -70°C until  use. Such  preparations  contain  both 
protein  and some lipid, and remain  active for as long as  12  mo under these 
conditions  (6). Fractions  that  contained  soluble  inhibitor  were brought  to 
isotonicity by addition  of l0 x  medium  and added to the cells in microtiter 
wells. 
Delipidation of the Solubilized Inhibitor:  Lipid was  removed 
from the solubilized material  by the procedure  of Dean and Tanford  (23) as 
described by Raben et al. (12). Soluble inhibitor,  obtained  as described above 
and still in the presence of octylglucoside, was precipitated by the addition  of 
0. l vol of I M sodium acetate, pH 4.0, and the resulting pellet was resuspended 
in  octylglucoside  buffer  at  a  concentration  of  l  mg/ml.  We  added  [SH]- 
cholesterol (250 nmol at 2 ~Ci/umol)  to this solution as a lipid marker. The 
inhibitor was then diluted with an equal volume of 30% (wt/vol) polyethylene 
glycol 6000, 40%  (vol/vol) glycerol in ocytlglucoside buffer. After 30 rain at 
4"C with occasional mixing the suspension was centrifuged at 104,000 g for 30 
rain. The pellet was suspended in the original volume of octylglucoside buffer 
and  the  precipitation  with polyethylene glycol was repeated.  The final pellet 
was then resospended in 0.5 ml buffer A and used for growth inhibition studies. 
Typically, 30% of the protein was recovered, whereas >99% oftbe added [SH]- 
cholesterol was found in the polyethylene glycol supernatants. 
RESULTS 
Effect of SLE on Proliferation of Lymphocytes 
SLE had a significant and dose-dependent suppressive effect 
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on  mitogen-induced proliferation of both T  and B cells iso- 
lated from mouse spleen (Fig.  1). DNA synthesis by B cells 
treated with  50  /~g/ml anti-IgM or 50 #g/ml  LPS was sup- 
pressed by 99% upon concurrent addition of 20/~g/ml SLE. 
T cells treated with  l0 #g/ml phytohemagglutinin or 3/~g/ml 
concanavalin A were also >95% inhibited at a similar dose of 
SLE.  A  trivial  explanation  of this  suppression  would  be  a 
toxic effect of SLE on these cells. This was ruled out by the 
observation that 20 ~g/ml SLE had no effect on cell viabilities 
24  h  after  addition  of SLE  to  anti-IgM-stimulated  B  cell 
cultures (Fig. 2). It is important to note that the unstimulated 
cells lost viability quickly, whereas stimulated  cells, even in 
the inhibitory presence of SLE, retained viability comparable 
to  the  unsuppressed  condition  up  to  24  h  after  mitogen 
addition. A further concern was that the suppressive effect of 
SLE was not protein  mediated,  as the  extract does contain 
lipid.  Stallcup and various co-workers (24, 25) have demon- 
strated that a  lymphocyte lipid component will inhibit lym- 
phocyte proliferation.  As an  indication  of the  fact that  the 
suppressive component is not a  lipid,  SLE incubated  for 15 
min at 80"C loses its suppressive activity against fibroblasts 
(2,  6). To compare the behavior of SLE with a  suppressive 
lipid,  we chose  25-hydroxycholesterol,  which  is highly  sup- 
pressive for lymphocytes (26, 27). While heat-treated SLE lost 
its suppressive ability, heat treatment of sterol and heat treat- 
ment  of the  combination  of SLE  and  sterol  did  not  affect 
their ability to inhibit  lymphocyte growth  (Fig.  3).  Though 
heat treatment of the SLE ablated its inhibitory capabilities, 
delipidation  did not (Table I). Furthermore,  lipids extracted 
from SLE by a  method similar to that of Stallcup et al. (24) 
had  no  suppressive effect (Table  I).  Indeed,  both  the  lipid 
extract and the heated SLE actually had some similar stimu- 
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FIGURE  1  DNA  synthesis  is suppressed  in  mito- 
gen-activated mouse lymphocytes exposed to SLE. 
B cells were stimulated with 50 ~.g/ml anti-lgM (A) 
and 50 ~g/ml LPS (B). These data are representative 
of five experiments. T cells were stimulated with 3 
/~g/ml concanavalin A  (C) and  10/~g/ml  PHA (D). 
These  data  are  representative  of  three  experi- 
ments. DNA synthesis was assayed as described in 
Materials and Methods. Both SLE (0, 5, 10, and 20 
/~g/ml) and the mitogen were added to the cells at 
time 0. Means +  SEM of triplicates. 
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FIGURE  2  SLE  is  not  cytotoxic.  B cells were cultured  in  24-well 
plates at 106 cells/ml per well for 2-24 h. Cells were either unstim- 
ulated  (control,  II)  or  stimulated  with  50  #g/ml  anti-lgM  in  the 
presence of either 0 (nl), 10 ([]), or 20 (m)/~g/ml SLE. Percent viable 
cells were determined by the method of fluorescein/ethidium bro- 
mide staining. 
latory activity. It is possible that this stimulatory component 
is  the  same  in  both  cases,  and  that  it  is  masked  by  the 
inhibitory  protein  in  SLE.  When  the  SLE  is  heated,  the 
inhibitory component is inactivated and the stimulatory com- 
ponent  reveals  itself.  In  any  case,  the  data  indicate  in  the 
lymphocyte  system  that  the  SLE  suppression  is  not  lipid 
mediated. 
Timing of SLE Effect and Relationship to Early 
Activation Events 
To determine the effective temporal window of SLE's reg- 
ulatory action, we added SLE to anti-IgM-stimulated  B cell 
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FIGURE  3  The  suppressive 
component of SLE is a protein, 
not a lipid. B cells were stim- 
ulated with  50 ~g/ml anti-lgM 
and treated as indicated, with 
2,  5,  and 20 p,g/ml  of the fol- 
lowing:  SLE, heat-inactivated 
SLE,  heat-inactivated  SLE  + 
25-hydroxycholesterol (sterol) 
(with  the  sterol  at  a  10-fold 
lower concentration than  the 
SLE), and 0.2, 0.5, and 2 ~g/ml 
heated  sterol  and  unheated 
sterol. All  data are expressed 
as percent change relative to 
stimulated,  untreated  control 
(5,000  cpm).  These  data  are 
representative of three exper- 
iments. 
TABLE  I.  Lipids Extracted from 5LE Fail To Suppress  Proliferation* 
Inhibitor  Concentration (ug/ml) 
0.2  0.5  2  5  20 
Sterol  -79%  -96%  -99%  ND  ND 
SLE  ND  ND  -78%  -90%  -98% 
Delipidated  ND  ND  -57%  -94%  -99% 
SLE* 
SLE lipids  ~  ND  ND  +54%  +23%  +86% 
* All data are expressed as percent change relative to control  stimulation 
(9,000 cpm) of DNA synthesis  {~H-TdR incorporation after a lO-h pulse with 
harvest at 72 h--mitogen and inhibitor  added at time 0). These data are 
representative of three experiments. 
* SLE delipidated with polyethyleneg[ycol as indicated in Materials and Meth- 
ods. 
Lipids were extracted from SLE as described by Stallcup et aL (25). 6 ml of 
chloroform:methanol  (2:1) were added to 0.6 ml of SLE (120 ,~g). After 
vigorous mixing and 30 min at 4*C, the phases  were separated by centrif- 
ugation, and the organic layer was obtained. This organic layer was mixed 
with 3 mI of buffer A, vortexed, and the organic layer obtained once again. 
The organic layer was then  dried  down under  N~,  and resuspended in 
buffer  A using bath sonication at the same volume  as the original SLE. 
Equivalent dilutions to those used in the SLE dose-response curve were 
then used. ND, not determined. 
cultures at varying times after the addition  of the mitogen 
(Fig. 4). The suppressive action of SLE (10/zg/ml) was greatly 
reduced  if the  addition  occurred  later  than  8-12  h  after 
mitogen addition. SLE added 12 h after mitogen addition had 
only a 22%  suppressive effect.  This contrasted to 85%  sup- 
pression when SLE was added with the mitogen at time 0. 
Since no differences in incorporation relative to control were 
observed when SLE was added with 3H-TdR at 62 h, we ruled 
out another trivial explanation: that SLE interferes with 3H- 
TdR  transport  or incorporation.  The  period  during  which 
SLE exerts its suppressive effect (0-12 h) is fairly early in the 
cell cycle. The maximum rate of DNA synthesis occurs 72 h 
after mitogen addition. Thus, for SLE to inhibit mitogenesis, 
it must be present early in the cell cycle, a time during which 
a  number of significant metabolic changes are occurring in 
mitogen-activated cells.  Such  events,  which  are  associated 
with the commitment of  the cell to enter G 1, include increased 
synthesis of phosphatidylinositol (15) and an increase in cell 
size (lymphoblast formation). We examined these events for 
an effect of SLE to determine whether a specific early response 
was  inhibited.  Two different  mitogens were  used  in  these 
experiments.  Anti-IgM  stimulation  of B  cells  results  in  a 
phosphatidylinositol response,  whereas LPS treatment does 
not (15). The lack of a phosphatidylinositol signal  from LPS 
has been attributed (15) to the ability of LPS to bypass the 
need for a phosphatidylinositol signal  by directly activating 
protein kinase C (28). Thus, for mitogens which can directly 
activate protein kinase C, phosphatidylinositol turnover is not 
an obligatory event; however for those mitogens which do not 
directly activate protein kinase C, phosphatidylinositol turn- 
over is required to activate this enzyme. Accordingly, anti- 
IgM  was  used  to  monitor  each  of the  activation  events: 
phosphatidylinositol turnover, blastogenesis, and DNA syn- 
thesis.  LPS was used to monitor only the latter two. 
The  incorporation  of 32pi into  phosphatidylinositol  was 
tested at 2 and 4 h after mitogen addition using a 2-h pulse 
of 3zPi before cell harvest. During this time period, the metab- 
olism of phosphatidylinositol is the most active of any of the 
phospholipids (15). 32pi activity incorporated into phosphati- 
dylinositol increased three- to fivefold in cells stimulated with 
50 ug/ml anti-IgM as compared to unstimulated cells. This 
level of incorporation in the stimulated cells was not altered 
by the concurrent addition  of 20 ~g/ml SLE (Table II). In 
contrast, cells treated with LPS and SLE did not substantially 
enlarge, as compared to control cells treated with LPS alone. 
As is shown in Fig. 5, the LPS-stimulated cells had enlarged 
by 48 h, whereas the cells treated with LPS and 20 ~g/ml SLE 
had a size profile comparable to cells treated with no mitogen. 
Aliquots  (0.2  ml)  of the  same  cells  assayed  for  cell  size 
enlargement were also assayed for DNA synthesis (data not 
shown). These same cells treated with 20 #g/ml SLE were, in 
addition  to their lack of a  blast response,  also >90%  sup- 
pressed in the later event of DNA synthesis.  Though the data 
shown involves LPS lymphoblasts, the data obtained using 
anti-IgM stimulated cells was equivalent. 
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FIGURE  4  Time course of SLE effect on proliferation. Mouse B cells 
were stimulated with 50 p.g/ml anti-lgM at time 0. 10 #g/ml SLE was 
added  at  time  indicated,  relative  to  mitogen  addition.  SLE  was 
added at 62 h concurrently with 3H-TdR, and at the final time point 
just before harvesting. These are representative results from one of 
two experiments. Means ±  SEM of triplicates. 
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Phosphatidylinositol Turnover 
Incubation* 
2h  4h 
No mitogen  2,280 ±  285  8,000 ±  658 
50 pg/ml anti-lgM  6,806 ±  1,509  28,090 +  3,166 
50 pg/ml anti-lgM +  7,753 ±  1,514  30,432 ±  5,093 
10 pg/ml SLE 
50 pg/ml anti-lgM +  7,956 _+ 789  31,976 ±  2,450 
20 pg/ml SLE 
"Cells were incubated for the times indicated after mitogen and SLE addition 
and  pulsed  with  32Pi 2  h  before  harvest as  indicated  in  Materials  and 
Methods.  All  data are cpm 32Pi incorporated into phosphatidylinositol-- 
mean of triplicates  +  SEM. These data are representative of three experi- 
ments. 
B Cells Require  B Cell Growth  Factor for 
Optimal  Mitogenesis 
BCOF  is thought to be required by the B  cell at 4-6  h  (19) 
after  mitogen  stimulation,  which  is  during the  time  of the 
suppressive extract's greatest inhibitory activity.  Enriched B 
cells treated  with  30 pg/ml anti-IgM and  10%  EL-4-condi- 
tioned  medium  incorporated  32,000  cpm 3H-TdR at  72  h, 
170%  greater  than  the  12,000  cpm  incorporated  by  cells 
stimulated with anti-IgM alone. Though DNA synthesis was 
greater  across  the  SLE  dose-response  curve  in  the  BCGF- 
supplemented cells,  the inhibition caused by SLE was com- 
parable at each dose of the inhibitor.  5 ug/ml SLE was 60% 
suppressive in cultures containing  10% BCGF, as compared 
to 62% in unsupplemented cells. The percentage suppression 
by  20  #g/ml  SLE  was  essentially  I00%  in  both  instances 
(<200 cpm). 
DISCUSSION 
We  have examined  the  suppressive  effect of a  mouse liver 
membrane  extract  on the  mitogen-induced  proliferation  of 
mouse lymphocytes. This extract inhibited  the proliferation 
of mouse fibroblasts (6). Four conclusions have emerged from 
our work. (a) SLE had a strong, dose-dependent, suppressive 
effect on mitogen-induced  proliferation  of mouse  T  and  B 
lymphocytes.  Addition  of 20  pg/ml  (expressed  as  protein 
concentration) of SLE caused a 95-99% suppression of DNA 
synthesis  in  both  T  and  B  cells,  regardless  of the  mitogen 
used. (b) Loss of suppressive activity upon heat treatment of 
SLE, together with retention of  this activity upon delipidation, 
indicates that the suppressive factor in SLE is a protein, and 
not  a  lipid.  (c)  The  suppressive  effect  of SLE  on  mouse 
lymphocytes extended to movement through G l, as indicated 
by a  failure  of B  cells  treated  with  both  LPS  and  SLE to 
undergo blastogenesis. Postponing the addition of the SLE 8- 
12 h after mitogen addition decreased the suppressive effect 
significantly. The suppressive effect did not extend to the early 
event  of increased  phosphatidylinositol  metabolism,  which 
was increased in stimulated  cells over unstimulated  control 
cells at 2 and 4 h, but unaffected by concurrent SLE addition. 
(d) Addition of B cell growth factor did nothing to relieve the 
extent of SLE suppression. This experiment suggests that the 
inhibitory  effect of SLE  is  not  a  result  of a  protein  in  the 
mixture competing with lymphocyte growth factors for access 
to the growth factor receptors. 
The question  of a  wider applicability  of this  suppressive 
phenomenon  led  us  to  the  experiments  with  lymphocytes 
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described  here.  The  very fact that  a  hepatocyte membrane 
extract is suppressive for fibroblast growth raises the possibility 
that some cell surface-mediated mechanisms of growth reg- 
ulation are comparable across a range of cell types including, 
now, lymphocytes. When SLE was added  12 h after mitogen 
addition it had little effect on DNA synthesis 60 h  later; this 
observation and the data on viability would seem to rule out 
a  simple toxic effect of the extract on lymphocytes. This is 
also supported by the fact that SLE had little suppressive effect 
on human lymphocytes (data not shown). Interestingly, lack 
of a  toxic effect of SLE is further borne out in tests on the 
one transformed  cell  line for which we have examined  the 
effect of SLE. EL-4 cells,  a  murine thymoma line (20),  are 
completely indifferent to SLE addition (data not shown). This 
further  differentiates  our  suppressive  activity  from  that  of 
Stallcup et al.  (24, 25), as that lipid inhibitor suppresses the 
proliferation of both normal and  transformed  lymphocytes. 
Mouse  fibroblast  membranes  have  been  shown  to  block 
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FIGURE  5  SLE  suppresses  mitogen-induced  cell  enlargement. 
Mouse enriched  B cells were cultured  for 48  h  at  106 cells/ml  in 
24-well cluster plates in the presence of 50 #g/ml LPS (A), 50 ,~g/ml 
LPS,  and  20  #g/ml  SLE  (B),  and  no  mitogen  (C).  The  cells  were 
resuspended and cell size determined on a Coulter CounterlChan- 
nelizer.  The  histogram  depicts  the  number  of  cells  at  each  cell 
volume. The results were similar for both anti-lgM and LPS in each 
of four experiments performed. growth factor-induced  mitogenesis in quiescent cells (29),  a 
situation quite analogous to what we have reported here. 
The fact that SLE-treated cells failed to enlarge upon mi- 
togenic  stimulus,  combined  with  the  fact  that  the  greatest 
suppressive effect on DNA synthesis occurred when SLE was 
provided within  12 h of the stimulus, indicates to us that the 
action of SLE is either early in or before G 1, well before the 
time when the cells have proceeded far enough along the cell 
cycle to enlarge significantly.  The small amount of suppres- 
sion that did occur upon addition of SLE at a time later than 
12  h  may  be  attributable  to  nonsynchronous  lymphocyte 
growth: at later times these ceils are spread out along the cell 
cycle to some extent. Extending this examination of activation 
landmarks,  we found no effect  of SLE on mitogen-induced 
activation of phosphatidylinositol turnover. This allows us to 
narrow the  target  of the growth  inhibitor's  effect  to a  time 
after entry of the cell into G 1 (marked by increased phospha- 
tidylinositol turnover),  but before the later G1  event of cell 
enlargement. 
The importance of cell-cell communication among the cells 
of the immune system is indisputable,  but what of the appli- 
cability  of our findings  to this system? Suppression  of lym- 
phocyte proliferation by the T  suppressor cell is not consid- 
ered to be an analogue of contact inhibition. Rather, mechan- 
istic explanations  have  focused  on a  variety of soluble sup- 
pressor factors secreted by suppressor T cells into their envi- 
ronment (30). A system more analogous to contact inhibition 
has been described by Lerner and Hodge (31) in the WiL 2 B 
lymphoblast  cell  line.  These cells  stop growing  at  high  cell 
density  and  resume  growth  upon  dilution.  As  mentioned 
above, Stallcup et al. (24) have described the preparation of a 
lymphoid cell membrane extract which inhibits both normal 
and transformed cell growth. This inhibitor is distinct  from 
the inhibitory component of SLE, as it is a lipid or lipidlike 
component which also acts on transformed cells (25). 
The extremely crowded environment of a lymphocyte in a 
lymph node is a very different one than found in the blood- 
stream. Though cell culture conditions of necessity resemble 
the latter,  it is in the former that most immune functioning 
actually takes place. It is also in such a crowded environment 
that  one  might  expect  direct cell  contact  phenomena,  both 
stimulatory  and  inhibitory,  to  be  of greatest  physiological 
relevance.  In this regard,  we note that SLE inhibits progress 
along the cell  cycle well  before the cells  have accomplished 
the great internal reorganization that is represented by cellular 
enlargement.  A  growth regulator that functions to keep cells 
in a quiescent state would be expected to act most efficiently 
by stopping cells early in the cycle. 
In summary, we have found a  fibroblast growth regulator 
produced  from  mouse  liver membranes  to  have  significant 
inhibitory  cross-reactivity with  cells of the murine immune 
system. The suppressive effect of SLE is manifested in a late 
(DNA  synthesis) and  an  intermediate  (blastogenesis)  event, 
but not in an early (increased  phosphatidylinositol  metabo- 
lism) event.  Experiments in progress include further charac- 
terizations of this  inhibitor,  together wtih  explorations  into 
the mechanism by which the factor stops lymphocyte prolif- 
eration early in G1. 
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